When Novo Nordisk tested compounded semaglutide samples and found over 24% impurities in some batches, it underscored that compounded medications don't undergo the same level of quality validation
SeekPeptides members access detailed protocol builders, vendor comparison tools, and direct guidance from experienced researchers who can help translate these concepts into practical decisions
doi: 10.1056/NEJMoa2511774
Finally, our findings offer a more comprehensive assessment compared with another analysis that produced indirect estimates between tirzepatide and semaglutide 2.0 mg using data solely from two RCTs [57]
reported that 1.8 mg/day liraglutide did not effectively reduce SBP compared to 4 mg/day glimepiride (a sulfonylurea) [89]
It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]